Lithium Carbonate

CHEMBL1200826 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
73.9 g/mol
LogP
Phase
4

The carbonate salt form of lithium, the most widely used preparation for treating bipolar disorder and preventing mood episodes. It requires careful blood level monitoring due to its narrow therapeutic window.

Peso Molecular

73,9000 g/mol

TPSA

63,20 Ų

Áreas Terapêuticas

Mecanismo de Ação

Modulates intracellular signaling via inositol and GSK-3 inhibition.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Modulates intracellular signaling via inositol and GSK-3 inhibition.

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C([O-])[O-].[Li+].[Li+]

InChI

InChI=1S/CH2O3.2Li/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2

Molecular Formula

CLi2O3

HBD / HBA

- / 3

Ligações Rotacionáveis

0

Átomos Pesados

6

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

The carbonate salt form of lithium, the most widely used preparation for treating bipolar disorder and preventing mood episodes. It requires careful blood level monitoring due to its narrow therapeutic window.

Modulates intracellular signaling via inositol and GSK-3 inhibition.

Yes, Lithium Carbonate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200826. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 11125. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.